Oral Glucose Tolerance Testing Using Candy for Cystic Fibrosis
NCT ID: NCT04579939
Last Updated: 2022-01-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2021-02-25
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Alternate Measures of Glucose During OGTT Testing for CFRD
NCT05568134
Cystic Fibrosis Related Diabetes Screening.
NCT02723968
Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT
NCT01883037
Experimental Study to Validate the Modified Glucose Disposal Test
NCT01152372
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
NCT02610179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
All 10 participants will go through the experimental arm receiving the dextrose candy oral glucose tolerance test.
Candy Glucose Tolerance Test
Participants will use a popular dextrose candy alternative to help assess glycemic response.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Candy Glucose Tolerance Test
Participants will use a popular dextrose candy alternative to help assess glycemic response.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cystic Fibrosis (CF) must be diagnosed.
* Ability to sign informed consent if they are 18 years or older.
* Written parental permission if age 10-17 years old.
Exclusion Criteria
* Use of steroids.
* Inability to tolerate oral feedings.
* Prior intestinal surgery.
* Concern for allergy or intolerance to dextrose, fructose, or corn derivatives.
10 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana L. Creo
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Creo, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-002446
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.